Full-Time

Medical Laboratory Scientist – Sr

Full-time, Kapiolani Medical Center','HI

Posted on 11/1/2025

Sonic Healthcare USA

Sonic Healthcare USA

51-200 employees

Laboratory and pathology testing services

Compensation Overview

$38.40 - $42.42/hr

+ Sign-on Bonus + Relocation

Honolulu, HI, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • The candidate must have a Bachelor's degree in Medical Technology/Medical Laboratory Science or related science from an accredited program.
  • The candidate must have current active certification from the American Society of Clinical Pathologists as a Medical Laboratory Scientist MT/CLS or MLS, or American Medical Technologists as Medical Laboratory Technician MLT.
  • The candidate must have a minimum of four years of clinical laboratory experience in a hospital or commercial lab setting.
  • The candidate must have good computer knowledge (Word and Excel) and skills in laboratory information systems.
  • Previous specialized experience in microbiology and blood banking is preferred for MT Senior assigned to these departments.
  • For hospital settings, additional requirements may apply and change without notice, including, but not limited to, criminal background checks, health clearance, and hospital compliance training.
  • The candidate must have successfully passed the company pre-employment drug screen and periodic and random thereafter.
  • The candidate must have a valid and current State of Hawaii license as a Technologist.
Responsibilities
  • The Senior Medical Laboratory Scientist is part of the management team and, as such, performs limited supervisory roles.
  • Each Senior Medical Laboratory Scientist will be assigned a specific area in which they will become a subject matter expert and assist the remainder of the management team, including the Laboratory Director, Technical Director, Laboratory Manager, and Supervisor, in assuring the area achieves accurate, reliable, and timely testing service.
  • Perform a vital part of the patient care process through moderate and high-complexity testing.
  • Analyze, review, and report testing results.
  • Recognize when corrective action is needed and implement effective solutions.
  • Work in a fast-paced laboratory environment with biological and chemical hazards
  • Champion safety, compliance, and quality control
Desired Qualifications
  • 2+ years of laboratory training or experience performing high-complexity testing within the area of specialty

Sonic Healthcare USA provides laboratory testing and professional pathology services across the United States as part of Sonic Healthcare Limited, one of the world’s largest medical diagnostics groups. It operates through nine divisions and around eight thousand employees, following a federated model that puts medical leadership at the local level to ensure high-quality, community-based testing for doctors and patients. Its tests cover core diagnostic laboratory services and pathology expertise used by medical practitioners, hospitals, and community health services. The company aims to deliver precise, timely results and strong clinical partnerships to improve patient care by offering comprehensive laboratory testing and pathology support while maintaining close ties to local healthcare providers.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Austin, Texas

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • Aging U.S. population drives cancer screening volumes through 2030.
  • National scaling via Sonic's sales and payer networks boosts Cairo reach.
  • Microba 19.99% stake opens gut health diagnostics expansion in 2025.

What critics are saying

  • Quest Diagnostics captures Cairo clients with faster oncology innovations within 12 months.
  • Labcorp diverts referrals using superior payer contracts in 15 months.
  • Medicare bundling slashes oncology reimbursements 20-30% post-Cairo integration.

What makes Sonic Healthcare USA unique

  • Cairo Diagnostics integrates hematology-oncology testing for comprehensive reports.
  • First major U.S. acquisition since 2021 targets high-margin oncology segment.
  • Bundled diagnostics from Cairo command premiums in competitive pathology market.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Company News

Newswise
Aug 22nd, 2025
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic's National Hematology Oncology Testing Capabilities

Sonic Healthcare USA, Inc. announces acquisition of Cairo Diagnostics LLC to expand Sonic's national hematology oncology testing capabilities.

PR Newswire
Aug 22nd, 2025
Sonic Healthcare Acquires Cairo Diagnostics

Sonic Healthcare USA, Inc. has acquired Cairo Diagnostics LLC to enhance its national hematology oncology testing capabilities. Founded by Dr. Sherif Ibrahim, Cairo is known for its integrated oncology testing approach, combining various diagnostic methods to provide comprehensive reports. This acquisition aims to expand Sonic's reach and improve service to oncologists nationwide, offering faster and more complete diagnostic solutions.

The West Australian
Mar 20th, 2024
Sonic Healthcare beefs up Swiss presence with $202m purchase of laboratory group Dr Risch

Sonic Healthcare will beef up its presence in Switzerland with the purchase of laboratory group Dr Risch for 117 million Swiss francs ($202m).

Business News Australia
Apr 27th, 2023
Sonic announces $611m in German acquisitions in April

Australias largest pathology company has today announced its second German acquisition this month, with binding agreements signed to purchase Medical Laboratori

Australian Financial Review
Nov 28th, 2022
Sonic Healthcare acquires major stake in Luke Reid’s Microba Life Sciences gut health testing business

Microba, an ASX-listed small-cap biotech, announced on Tuesday morning that Sonic would invest $17.8 million to acquire a 19.99 per cent stake in the company at 26¢ per share.

INACTIVE